circ_103809 promotes breast cancer progression by regulating the PI3K/AKT signaling pathway

被引:38
作者
Qiu, Xiaoli [1 ]
Wang, Qinghua [1 ]
Song, Huiping [1 ]
Shao, Di [1 ]
Xue, Jie [1 ]
机构
[1] Linyi Canc Hosp, Dept Galactophore, 6 Lingyuan East St, Linyi 276000, Shandong, Peoples R China
关键词
circ_103809; proliferation; apoptosis; PI3K; AKT; breast cancer; PROLIFERATION; RNAS;
D O I
10.3892/ol.2020.11507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is one of the most common cancer types in the world. This study was carried out to investigate the functional role of circular RNA circ_103809 in breast cancer. The expression of hsa_circ_103809 in breast cancer tissues and breast cancer cells were verified. After transfection, the expression of hsa_circ_103809 in the cells was detected by quantitative real-time polymerase chain reaction (qRT-PCR). Cell counting kit-8 (CCK-8) and colony formation assay were used to detect cell proliferation. Apoptosis and cell cycle were detected by flow cytometry. AKT, p-AKT, BCL2 and Bax were detected by western blotting. Tumor formation assay was employd in vivo. The expression of circ_103809 in breast cancer was overexpressed. circ_103809 was proved to promote cell proliferation in breast cancer progression. In addition, circ_103809 was also involved in repressing cell apoptosis and accelerating cell cycle progression in vitro. circ_103809 accelerated breast cancer progression via regulating PI3K/AKT signaling. circ_103809 promoted tumor formation in vivo. The circular RNA hsa_circ_103809 was highly expressed in breast cancer tissues and cells, and may play an oncogene role in the development of breast cancer, and is expected to become a new target for breast cancer therapy.
引用
收藏
页码:3725 / 3730
页数:6
相关论文
共 16 条
[1]   circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a [J].
He, Rongfang ;
Liu, Peng ;
Xie, Xiaoming ;
Zhou, Yujuan ;
Liao, Qianjin ;
Xiong, Wei ;
Li, Xiaoling ;
Li, Guiyuan ;
Zeng, Zhaoyang ;
Tang, Hailin .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
[2]   Functional miRNAs in breast cancer drug resistance [J].
Hu, Weizi ;
Tan, Chunli ;
He, Yunjie ;
Zhang, Guangqin ;
Xu, Yong ;
Tang, Jinhai .
ONCOTARGETS AND THERAPY, 2018, 11 :1529-1541
[3]   PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a [J].
Huang, Xiaojia ;
Xie, Xinhua ;
Wang, Hua ;
Xiao, Xiangsheng ;
Yang, Lu ;
Tian, Zhi ;
Guo, Xiaofang ;
Zhang, Lijuan ;
Tang, Hailin ;
Xie, Xiaoming .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
[4]  
Liang HF, 2017, AM J CANCER RES, V7, P1566
[5]   Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer [J].
Lu, Lingshuang ;
Sun, Jian ;
Shi, Peiyi ;
Kong, Weimin ;
Xu, Kun ;
He, Biyu ;
Zhang, Simin ;
Wang, Jianming .
ONCOTARGET, 2017, 8 (27) :44096-44107
[6]   Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options [J].
McAnena, Peter F. ;
Brown, James A. L. ;
Ramli, A. ;
Curran, C. ;
Malone, C. ;
McLaughlin, R. ;
Barry, K. ;
Brown, J. A. L. ;
Kerin, M. J. .
BMC CANCER, 2018, 18
[7]   Natural Products for the Management and Prevention of Breast Cancer [J].
Mitra, Sarmistha ;
Dash, Raju .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
[8]   SCRAMBLED EXONS [J].
NIGRO, JM ;
CHO, KR ;
FEARON, ER ;
KERN, SE ;
RUPPERT, JM ;
OLINER, JD ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1991, 64 (03) :607-613
[9]   Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis [J].
Wang, Honglei ;
Xiao, Yi ;
Wu, Li ;
Ma, Dachang .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) :743-754
[10]   Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316 [J].
Wang, Nan ;
Gu, Yuanting ;
Li, Lin ;
Wang, Fang ;
Lv, Pengwei ;
Xiong, Youyi ;
Qiu, Xinguang .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2018, 653 :63-70